In this issue of Cell, Lin et al. (2006) answer one of the long-standing questions in the TGFβ field by identifying a phosphatase, PPM1A, that directly dephosphorylates Smad2 and Smad3 to limit their activation.
Transforming growth factor β (TGFβ) signaling regulates numerous biological processes in a variety of cell types in organisms ranging from worms to humans (Shi and Massague, 2003) . Despite the amazingly diverse set of cellular responses regulated by TGFβ, from proliferation and apoptosis to cellular differentiation and motility, the central signaling pathway downstream of TGFβ is surprisingly simple. TGFβ binds to its receptors at the cell surface, facilitating phosphorylation of the type I receptor (TβRI) by the type II receptor (TβRII). The activated TβRI then phosphorylates the receptor-activated Smads (R-Smads) Smad2 and Smad3 at two serines in their C-terminal SXS motif-a crucial step in the transduction of a TGFβ signal. Phosphorylation alters the conformation of the R-Smads, relieving their autoinhibition and releasing them from cytoplasmic retention proteins such as the Smad anchor for receptor activation (SARA) or microtubules.
These conformational changes also increase the affinity of the R-Smads for the common Smad (Co-Smad), Smad4, to facilitate complex formation. The resulting Co-Smad-R-Smad complexes then translocate to the nucleus and interact with different sets of cofactors to regulate expression of specific target genes, leading to a particular biological response.
To enable the relatively simple TGFβ signaling pathway to influence such diverse biological events, many layers of tight regulation exist to control not only the level and duration of pathway activation but also what genes and responses are induced in different cell types and contexts. This regulation occurs at all levels of the TGFβ signaling pathway. The expression, bioavailability, and activation of TGFβ ligands are highly regulated, as is the expression of the type I and type II receptors. Regulation at this level dictates whether the TGFβ signaling cascade is even initiated. Once initiated, the TGFβ signal is regulated by crosstalk with other signaling pathways to either blunt or augment TGFβ-regulated transcription. Finally, the expression patterns and levels of Smads and their binding partners further fine tune transcriptional responses, allowing a diverse array of distinct cell type-and context-specific effects.
The mechanism through which these activated pathways are terminated is also a highly regulated process. Reductions in the levels of active TGFβ ligand, internalization and degradation of the TGFβ receptors, and inhibition of receptor activity through induction of the inhibitory Smads (I-Smads), Smad6 and Smad7, are all means through which the TGFβ signal is terminated upstream of the R-Smads. However, elucidating the mechanisms by which the TGFβ signal is terminated at the level of the R-Smads has proven a more difficult task. Initially, it was thought that the level of activated R-Smads in the nucleus was reduced by ubiquitin-mediated proteasome degradation (Lo and Massague, 1999) . Although this is true to some extent, more recent findings suggest that the majority of activated R-Smads are not degraded but recycled (Pierreux et al., 2000) and that dephosphorylation is a prerequisite for the recycling of R-Smads (Inman et al., 2002) . A phosphatase capable of dephosphorylating a BMP-regulated R-Smad, Smad1, was recently identified (Chen et al., 2006) , although the phosphatase (or phosphatases) capable of catalyzing dephosphorylation of Smad2 and Smad3 had remained unknown until this issue of Cell, where the identity of one of these elusive phosphatases is revealed in ground-breaking work by Xin-Hua Feng and collaborators (Lin et al., 2006) .
In the study by Lin et al. (2006) , expression plasmids were generated for the catalytic subunits of 39 different human phosphatases. Out of these 39, only expression of PPM1A/PP2Cα reduced Smad2 phosphorylation induced by a constitutively active TβRI in 293T cells, and this reduction did not require proteasome-mediated degradation. Knockdown of PPM1A using shRNA had the opposite effect, increasing the levels of P-Smad2/3-an effect that was rescued by expression of zebrafish PPM1A. Furthermore, Smad2 and PPM1A colocalized in the nucleus following a TGFβ signal, and an interaction between the two endogenous proteins was stimulated by TGFβ. It is clear from these results that PPM1A is a phosphatase capable of dephosphorylating Smad2/3 following TGFβ-induced activation.
Based on previous studies, it was thought that dephosphorylation of R-Smads by a nuclear phosphatase initiates the dissolution of the RSmad/Co-Smad complex (Inman et al., 2002) . Consistent with this idea, the dephosphorylation of Smad2/3 by PPM1A directly affected the ability of Smad2 and Smad3 to remain in complexes with Smad4 and resulted in the export of Smad2 and Smad3 from the nucleus. In cells with decreased expression of PPM1A, there was an increase in the translocation of Smad2/3 to the nucleus in response to TGFβ and a corresponding increase in complex formation between Smad2 and Smad4. On the other hand, expression of PPM1A abolished complex formation between Smad2/3 and Smad4 and increased the nuclear export of Smad2 but not control proteins. Importantly, expression of a PPM1A mutant incapable of dephosphorylating Smad2/3 had no effect on these processes.
PPM1A also affects transcription and biological responses downstream of Smad signaling. Depletion of PPM1A made HaCaT cells more sensitive to the growth-inhibitory effects of TGFβ. This correlated with changes in the expression of genes that are known to mediate TGFβ-induced growth inhibition, as there was a greater induction of p15 and p21 and an accelerated repression of cmyc by TGFβ in the PPM1A-depleted cells. Similarly, inducible expression of PPM1A in Mv1Lu cells reduced the growth inhibition induced by TGFβ, whereas the inducible expression of PPM1A mutants that are incapable of dephosphorylating Smad2/3 had no effect. As expected, these outcomes were specific to the effects of PPM1A on Smads. In PPM1A-depleted cells, simultaneous knockdown of Smad2 and Smad3 abolished the activity of the p21 promoter that is induced by TGFβ, whereas treatment with inhibitors of non-Smad pathways activated by TGFβ had no effect. Most importantly, PPM1A appears to influence Smad signaling across species as well. Ectopic expression of PPM1A antagonized the dorsalizing activity of Nodal (the zebrafish equivalent of TGFβ) and phenocopied mutant zebrafish embryos that lack Nodal, indicating a role for PPM1A in regulating Nodal signals mediated by Smad2/3 during zebrafish embryonic development.
This breakthrough study has opened up several new areas of investigation. It is possible that PPM1A is always active, permitting R-Smads to constantly cycle between the cytoplasm and nucleus. This would allow the R-Smads to sense the status of the receptors, thus enabling efficient termination of the TGFβ signal upon receptor inactivation. On the other hand, PPM1A expression, activity, and subcellular localization may be actively regulated. In this case, biological signals capable of regulating PPM1A would have the potential to either augment or blunt responses to TGFβ. TGFβ has no effects on the subcellular localization, expression, or activity of PPM1A (Lin et al., 2006) . Thus, PPM1A does not appear to serve as a negative feedback loop for this signaling pathway. However, one could speculate that regulation of PPM1A may play a role in multiple situations in which TGFβ signaling is blunted. For example, a recent study demonstrated that T cells lacking Gαi2 show decreased phosphorylation of Smad2 and Smad3 (Wu et al., 2005) . As this does not occur through changes in TGFβ receptor or Smad7 expression, perhaps there is increased activity of PPM1A in the cells lacking Gαi2.
Another interesting question raised by this study is how basal expression levels of PPM1A contribute to the sensitivity of cells to a TGFβ signal. PPM1A is expressed at various levels in different cell and tissue types. Whereas PPM1A is easily detected in some cell types, such as epithelial cells, it is expressed at very low levels in fibroblasts and endothelial cells (Lifschitz-Mercer et al., 2001) . Is TGFβ signaling enhanced in these cell types, or do these cells have additional phosphatases that are capable of dephosphorylating the Smad2/3 SXS motif? Similarly, PPM1A expression may be altered in pathophysiological contexts such as cancer, either reducing TGFβ-mediated growth inhibition and apoptosis or enhancing TGFβ-mediated metastasis. Given that reducing the concentration of activated R-Smads and reducing the duration of activation eliminates certain TGFβ-induced gene responses while leaving other responses intact (Nicolas and Hill, 2003) , PPM1A may contribute to the diversity and context-dependent specificity of TGFβ signaling through its ability to fine tune Smad activation. It will be exciting to learn more about how the expression and regulation of PPM1A influences TGFβ signaling in different physiological and pathophysiological contexts.
It is clear that PPM1A plays a crucial role in TGFβ signaling by regulating the level of R-Smad phosphorylation, but the specificity and selectivity of PPM1A for R-Smads remains to be seen. Lin et al. (2006) report that within the R-Smad molecules, PPM1A appears to show specificity in dephosphorylating the SXS motif, as phosphorylated Ser212 of Smad3 (a target of Cdk4) is not dephosphorylated by PPM1A (Lin et al., 2006) . However, there is evidence that PPM1A may also target other pathways or proteins, including the p38 and PI3K pathways, that interact with or can be activated by TGFβ in certain contexts (Takekawa et al., 1998; Yoshizaki et al., 2004) . Despite this, induction of p38 or Akt phosphorylation by TGFβ is not reduced by PPM1A in Mv1Lu or NIH 3T3 cells (Lin et al., 2006) . Although the major role of PPM1A may be to impinge on TGFβ-regulated Smad signaling, it nonetheless appears certain that PPM1A has other targets and functions. These other functions may be concordant with the downstream effects of PPM1A-mediated dephosphorylation of Smad2/3, or they may be completely independent of the effects of PPM1A on Smad2/3. Teasing apart how these various pathways may be connected or regulated independently by PPM1A will be an interesting challenge for the future.
Organogenesis depends upon a well-ordered series of events involving coordination of the molecular pathways that regulate the generation and patterning of specific cell types. A key question is whether regulatory networks for cell differentiation and patterning overlap or are separate processes. Skeletal development is an excellent context for investigating this complex problem because of the wealth of information emerging on molecular mechanisms that govern both skeletal differentiation and patterning from studies of model organisms and human mutations (Karsenty and Wagner, 2002) . For example, members of the Hox homeodomain family of transcription factors are major regulators of skeletal patterning, whereas the Runt domain protein Runx2 is a master regulator of transcription that controls osteoblast differentiation. The patterning of skeletal elements and bone formation are generally thought to represent distinct pathways; how-
